ProMIS (PMN) CDO Johanne Kaplan Buys 2,280 Shares

What Happened
Johanne Kaplan, Chief Development Officer of ProMIS Neurosciences (PMN), purchased 2,280 shares on August 5, 2026 at $13.30 per share, for a total cost of $30,324. This was a direct purchase (Form 4 code "P") — purchases can be seen by investors as more informative than routine sales, though the filing itself does not state Kaplan’s motivation.

Key Details

• Transaction date: 2026-08-05; Price: $13.30 per share; Shares acquired: 2,280; Total value: $30,324.
• Transaction type: Purchase (Form 4 code P); described as open-market or private purchase on the filing.
• Filing date: 2026-08-07 — filed within the standard two-business-day Form 4 window (timely).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• No 10b5-1 plan, gift, option exercise, or tax-withholding footnotes were reported in the data provided.

Context
This was a straight share purchase (not an option exercise or award). Retail investors often watch insider purchases as a potential positive signal, since executives are putting personal capital into the company; however, the filing does not explain intent, and one trade alone should not be taken as a forecast of company performance.